The Liver Meeting 2022
New Agent Shows Promise in Decompensated Cirrhosis
The novel agent GB1211, an oral galectin-3 inhibitor, led to meaningful reductions in liver enzymes among some ...
MAY 11, 2023
Potential Biomarker Found for Inherited Liver Disease
Blood levels of a biomarker for liver disease activity in patients with the inherited disease homozygous Z allele ...
MAY 11, 2023
Load more